10x Genomics (NASDAQ:TXG) announced on Monday that its ATAC-Seq patents were found valid and infringed in its patent litigation with Parse Biosciences. On February 25, 2025, a consent agreement ...

Unlike RNA sequencing, which provides information about the genes that are being expressed, ATAC-Seq (A(ssay for) T(ransposase)-A(ccessible) C(hromatin using) Seq(uencing)) provides a genome-wide ...